A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.